Tilray Brands, Inc. (TLRY)
TLRYNASDAQ-GS Medicinal Chemicals and Botanical Products
$2.64
-0.2100 (-7.37%) today
Regular session, Nov 10, 1:10 PM ET
- Market cap
- $390.16m
- P/E
- –
- EPS, last 4 quarters
- $-1.40
- Dividend yield
- –
- Day range
- $2.63 to $2.84
- 52-week range
- $2.49 to $15.70
- Average volume
- 4.28m
- Previous close
- $2.85
Analysts
7 coveringHold3 buy, 4 hold, 0 sell
Targets a year out average $6.19, +134.5% from here
Earnings
next estimate $-0.1500Next report
Nov 2025
-192.9%
Feb 2026
-71.4%
May 2026
-2050.0%
Aug 2026
-68.4%
estimate reported, and the surprise
Financials
| Quarter | Nov 2025 | Feb 2026 | May 2026 | Aug 2026 |
|---|---|---|---|---|
| Revenue | $217.51m | $206.73m | $281.71m | $257.15m |
| Gross profit | $57.50m | $54.95m | $90.52m | $77.51m |
| Operating income | -$22.28m | -$26.39m | -$16.45m | -$24.05m |
| Net income | -$43.51m | -$25.23m | -$37.93m | -$40.03m |
Last four quarters: revenue $963.10m, margin -15.2%, free cash flow -$118.82m
News
8 latest- Does Marijuana Rescheduling Really Help Tilray's Stock?The Motley Fool · 6 hours ago
- Tilray Raises Its Guidance for the Year. Is the Stock Finally Headed on the Right Track?The Motley Fool · 1 day ago
- Which of These 5 Cannabis Stocks Has the Strongest Balance Sheet?The Motley Fool · 2 days ago
- Tilray Brands, Inc. (TLRY) is Attracting Investor Attention: Here is What You Should Know Zacks · 5 days ago
- Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are MissingThe Motley Fool · Nov 1, 2026
- Tilray Just Posted Record Quarterly Revenue of $257 Million. So Why Did Its Cannabis Sales Shrink?The Motley Fool · Nov 1, 2026
- Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in CannabisThe Motley Fool · Oct 30, 2026
- Post-Q3 Earnings: Is SNDL Stock a Portfolio Must-Have?Zacks · Oct 28, 2026
The company
Tilray Brands, Inc. ('Tilray') (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment elevating lives through moments of connection. Tilray's mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray's unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- tilray.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.